Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 19;7(8):ofaa235. doi: 10.1093/ofid/ofaa235

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Changes in the detection rate and load of EBV at stable visits and during the natural course of AEs and convalescence. A, Changes in the EBV detection rate and EBV load (log₁₀ load) during the natural course of AEs and convalescence. B, Change in the EBV load at stable visits and during the natural course of AEs and convalescence within the same bronchiectasis patient. C, Change in the EBV load at stable visits and during the natural course of AEs and convalescence in patients with and without cold symptoms. Data are presented as percentage and mean (SD). The numbers appearing at different time points indicate the log₁₀ load for EBV in sputum. The colors in Figure 2B represent different individual bronchiectasis patients. Day 1: within 2 (IQR, 2.0–3.3) days of the onset of AE symptoms; Poststable: median 45 (IQR, 40–54) days from the onset of AE symptoms. Abbreviations: AE, adverse event; EBV, Epstein-Barr virus; IQR, interquartile range.